Search - tctmd.com

Displaying 381 - 400 of 473

Sort: Relevancy | Date

News Daily News

Tras la TAVR, las Mujeres experimentan una Recuperación VI Más Rápida que los Hombres

L.A. McKeown

June 11, 2012

News Daily News

After TAVR, Women Show Faster LV Recovery Than Men

L.A. McKeown

June 11, 2012

Presentation

Impact of Gender on 3-Month Outcome and Left Ventricular Remodeling After Transfemoral TAVR

Presenter: Verena Stangl

June 08, 2012

News Daily News

Antianginal Drug May Reduce Periprocedural MI in Elective PCI

Yael L. Maxwell

June 08, 2012

News Industry News

CardioKinetix Announces Positive Two-Year Clinical Data for First-of-Its-Kind Minimally Invasive Treatment for Heart Failure

May 18, 2012

News Industry News

New Data From Landmark Study Shows Cost-Effectiveness of Medtronic Life-Saving CRT-D Therapy in Mildly Symptomatic Heart Failure Patients

May 11, 2012

News Daily News

Several Factors Behind False-Positive STEMI Activations

Yael L. Maxwell

May 09, 2012

News Daily News

TAVR Suitable Even in Patients with Impaired LVEF

Caitlin E. Cox

April 19, 2012

News Daily News

La TAVR es Apta Incluso para Pacientes con LVEF Deteriorada

Caitlin E. Cox

April 19, 2012

Presentation

Transcatheter Aortic Valve Implantation in Pts with Severe Left Ventricular Dysfunction

Presenter: Chiara Fraccaro

April 18, 2012

News Industry News

Medtronic Receives FDA Approval to Treat Mildly Symptomatic Heart Failure Patients Through Expanded Indication for CRT-D

April 10, 2012

News Daily News

La Puntuación Residual Syntax Predice los Resultados Tras una Revascularización Incompleta

L.A. McKeown

April 10, 2012

News Daily News

Study Investigates Impact of Moderate or Severe MR in TAVR Patients

Jason Kahn

April 06, 2012

Presentation ACC 2012

Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Ischemic Heart Failure: The FOCUS-CCTRN Trial

Presenter: Emerson C. Perin

March 25, 2012

News Conference News ACC 2012

BCIS-1: Long-Term Follow-up Shows Lower Mortality with Elective IABP Therapy

Jason Kahn

March 25, 2012

News Conference News ACC 2012

Stem Cell Therapy Fails to Show Benefit in Chronic Ischemic Heart Failure

L.A. McKeown

March 24, 2012

News Daily News

IABP Use Most Risky in ACS Patients Undergoing Urgent PCI

March 22, 2012

News Daily News

Hemodynamic Index Helps Define Impact of Aortic Regurgitation After TAVR

March 21, 2012

News Industry News

Boston Scientific Announces New Clinical Data to be Presented at ACC 2012 on the Market-Leading PROMUS Element™ Stent

March 20, 2012

News Industry News

Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012

March 20, 2012

Advertisement

Tras la TAVR, las Mujeres experimentan una Recuperación VI Más Rápida que los Hombres

After TAVR, Women Show Faster LV Recovery Than Men

Impact of Gender on 3-Month Outcome and Left Ventricular Remodeling After Transfemoral TAVR

Antianginal Drug May Reduce Periprocedural MI in Elective PCI

CardioKinetix Announces Positive Two-Year Clinical Data for First-of-Its-Kind Minimally Invasive Treatment for Heart Failure

New Data From Landmark Study Shows Cost-Effectiveness of Medtronic Life-Saving CRT-D Therapy in Mildly Symptomatic Heart Failure Patients

Several Factors Behind False-Positive STEMI Activations

TAVR Suitable Even in Patients with Impaired LVEF

La TAVR es Apta Incluso para Pacientes con LVEF Deteriorada

Transcatheter Aortic Valve Implantation in Pts with Severe Left Ventricular Dysfunction

Medtronic Receives FDA Approval to Treat Mildly Symptomatic Heart Failure Patients Through Expanded Indication for CRT-D

La Puntuación Residual Syntax Predice los Resultados Tras una Revascularización Incompleta

Study Investigates Impact of Moderate or Severe MR in TAVR Patients

Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Ischemic Heart Failure: The FOCUS-CCTRN Trial

BCIS-1: Long-Term Follow-up Shows Lower Mortality with Elective IABP Therapy

Stem Cell Therapy Fails to Show Benefit in Chronic Ischemic Heart Failure

IABP Use Most Risky in ACS Patients Undergoing Urgent PCI

Hemodynamic Index Helps Define Impact of Aortic Regurgitation After TAVR

Boston Scientific Announces New Clinical Data to be Presented at ACC 2012 on the Market-Leading PROMUS Element™ Stent

Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content